Meredith Faggen MD

Clinical Instructor in Medicine, Dana-Farber Cancer Institute

541 Main StSte 414South Weymouth, MA 02190
Phone+1 781-952-1650
Fax+1 781-331-4936

Dr. Faggen is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Faggen's full profile Already have an account?

Education & Training

Rhode Island Hospital/Brown University HealthFellowship, Hematology and Medical Oncology, 2006 - 2009
Yale-New Haven Medical CenterResidency, Internal Medicine, 2002 - 2005
Tulane University School of MedicineClass of 2002

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

MA State Medical License 2009 - 2028
CT State Medical License 2004 - 2009
RI State Medical License 2006 - 2007
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 2 Certification OpTime Surgical 2014 Certified Module, Epic Systems Corporation, 2012, 2014-2015, 2017
CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014-2015, 2017
CMS Meaningful Use Stage 1 Certification Partners Longitudinal Medical Record, Partners Healthcare System, 2012, 2014-2015, 2017

Clinical Trials

Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Feb 08
COMPLETED
PHASE3

Publications & Presentations

PubMed

Neoadjuvant Paclitaxel, Trastuzumab, and Pertuzumab for Stage II to III, ERBB2-Positive Breast Cancer: A Secondary Analysis of the DAPHNe Trial.
Paolo Tarantino, Tianyu Li, Esther Ritah Ogayo, Tasnim Rahman, Molly K DiLullo
JAMA Oncology. 2026-08-01
Association between self-reported breast cancer knowledge and clinical trial participation in patients with triple-negative breast cancer.
Megan E Tesch, Noah Graham, Craig Snow, Catherine E Stever, Tonia S Parker
Breast Cancer Research and Treatment. 2026-07-30
Research Letter: Frailty Within a Cohort of Older Adults With Breast Cancer: Groundwork for Future Geriatric-Specific Outcomes Data.
Christina A Minami, Hillary M Heiling, Nabihah Tayob, Melissa E Hughes, Craig Snow
Journal of the American Geriatrics Society. 2026-06-03